Lauren Handelman, MD
Allergy & Immunology · Newton, MANPI 1548358930
Payments from drug & device makers
Across 708 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Pfizer$825
- AbbVie$760
- Blueprint Medicines Corporation$655
- plus $6K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 154 | $3,847 |
| GSK | 97 | $1,715 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,336 |
| Pfizer | 43 | $825 |
| AbbVie | 33 | $760 |
| Blueprint Medicines Corporation | 23 | $655 |
| CSL Behring | 27 | $582 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $569 |
| Novartis | 30 | $552 |
| Sanofi | 23 | $548 |
| Genentech USA, Inc. | 41 | $548 |
| Amgen(2 entities) | 37 | $539 |
| Kaleo, Inc. | 26 | $464 |
| Biocryst US Sales Co., LLC | 13 | $302 |
| Pharming Healthcare, Inc. | 11 | $233 |
| Grifols USA, LLC | 11 | $194 |
| Boehringer Ingelheim | 7 | $168 |
| Teva Pharmaceuticals USA, Inc. | 9 | $154 |
| Aimmune Therapeutics, Inc. | 8 | $151 |
| Incyte Corporation | 7 | $141 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $137 |
| Lilly USA, LLC | 4 | $93 |
| Covis Pharma GmbH | 4 | $71 |
| Cycle Pharmaceuticals Inc | 2 | $66 |
| Alk-abello, Inc | 3 | $62 |
| Eyevance Pharmaceuticals LLC | 2 | $26 |
| Octapharma USA, Inc. | 1 | $25 |
| Invivyd Inc | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $24 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$14,874 in reported general payments places this provider in the 65th percentile of 114 allergy & immunology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Newton
- S David MillerNorth Dartmouth$8.7M
- Wanda PhipatanakulBoston$3.2M
- Maria CastellsGardner$2.8M
- Rima RachidBoston$1.1M
- Duane WesemannBoston$1M
- Matthew GiannettiBoston$720K
- John LeeBoston$695K
- Aleena BanerjiBoston$586K
- Michael PistinerBoston$468K
- Kathleen BuchheitBoston$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.